- Investing Ideas
- /
- Global Biotech Breakthroughs
Global Biotech Breakthroughs
Results
84
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
84 companies
Innovent Biologics
Market Cap: HK$96.7b
A biopharmaceutical company, develops, manufactures and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in China.
1801
HK$58.60
7D
14.9%
1Y
63.2%
Seegene
Market Cap: ₩1.5t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩32,200.00
7D
4.0%
1Y
50.8%
Kiniksa Pharmaceuticals International
Market Cap: US$1.9b
A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.
KNSA
US$26.89
7D
2.4%
1Y
41.2%
Dynavax Technologies
Market Cap: US$1.2b
A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.
DVAX
US$9.80
7D
1.3%
1Y
-14.0%
Diamyd Medical
Market Cap: SEK 952.8m
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 9.12
7D
-6.5%
1Y
-20.6%
CStone Pharmaceuticals
Market Cap: HK$4.8b
A biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in China and internationally.
2616
HK$3.54
7D
23.8%
1Y
172.3%
Mabion
Market Cap: zł163.2m
A biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland.
MAB
zł10.10
7D
-1.6%
1Y
-42.7%
Mirum Pharmaceuticals
Market Cap: US$2.2b
A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
MIRM
US$44.00
7D
-2.2%
1Y
79.2%
Pharming Group
Market Cap: €635.0m
A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.
PHARM
€0.93
7D
8.7%
1Y
11.6%
Organogenesis Holdings
Market Cap: US$376.8m
A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.
ORGO
US$2.90
7D
-5.8%
1Y
10.3%
Formycon
Market Cap: €392.9m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€22.25
7D
-2.8%
1Y
-47.2%
Natera
Market Cap: US$20.8b
A diagnostics company, provides molecular testing services worldwide.
NTRA
US$153.32
7D
0.5%
1Y
40.0%